New imaging modalities are taking away much of the work formerly done by cardiac and vascular x-ray-based procedures, and today's customers may reconsider or postpone investment decisions in the newer, more expensive cardiac and vascular x-ray technologies, according to an analysis from Frost & Sullivan of San Jose, CA.
CT and MRI are making inroads into vascular imaging using contrast agents. The market for vascular imaging is still healthy, though, producing revenue of $775.4 million in 2003, and a predicted $1 billion in 2010.
Some observers believe that cardiac x-ray will still be used to verify the results of CR and MR diagnostic exams, and that cardiovascular CT or MR will simply redistribute the x-ray procedure volume from a diagnostic case load to an interventional one, according to the report.
Frost & Sullivan's report is part of its U.S. Cardiac and Vascular X-ray Equipment Markets.
By AuntMinnie.com staff writers
November 16, 2004
Related Reading
European contrast market shows volatility, October 21, 2004
European mobile imaging equipment market on the rise, September 8, 2004
F&S report: European rules stifle innovation, July 27, 2004
Gamma camera market set to show 3.1% growth rate, July 6, 2004
Frost predicts tripling of non-mammo breast imaging in U.S., December 9, 2003
Copyright © 2004 AuntMinnie.com
